Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)
- PMID: 9772277
- DOI: 10.3892/ijo.13.5.893
Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review)
Abstract
Tumor cell migration and invasion into the surrounding tissue depend on the invasive capacity of cells leading to the loosening of cell-cell and cell-substratum contacts via cell surface associated proteolytic enzyme systems. Plasmin is one of the enzymes involved in these complex events. It is generated by the cleavage of the proenzyme plasminogen upon the action of the urokinase-type plasminogen activator (uPA). uPA is synthesized and secreted by tumor cells and normal cells and interacts with a specific cell surface receptor (uPAR) thereby focalizing enzymatic activity to the cell surface. The activity of uPA is controlled by plasminogen activator inhibitors type-1 and type-2. A strong statistically independent prognostic impact has been attributed to uPA and its inhibitor PAI-1 in a variety of malignancies. Besides its proteolytic activity, uPA in concert with uPAR exert biological effects characteristic for molecules with signal transducing properties including chemotaxis, migration/invasion, adhesion, and mitogenesis.
Similar articles
-
[Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].Nihon Sanka Fujinka Gakkai Zasshi. 1996 Aug;48(8):623-32. Nihon Sanka Fujinka Gakkai Zasshi. 1996. PMID: 8808830 Review. Japanese.
-
[The urokinase-type plasminogen activator system and its role in tumor progression].Biomed Khim. 2018 Nov;64(6):472-486. doi: 10.18097/PBMC20186406472. Biomed Khim. 2018. PMID: 30632975 Review. Russian.
-
The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer.Clin Biochem. 2004 Jul;37(7):541-8. doi: 10.1016/j.clinbiochem.2004.05.013. Clin Biochem. 2004. PMID: 15234235 Review.
-
Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S46-58. doi: 10.1097/01.blo.0000093845.72468.bd. Clin Orthop Relat Res. 2003. PMID: 14600592 Review.
-
[The clinical prospects for the study of the plasminogen activation system in breast cancer].Vestn Ross Akad Med Nauk. 1999;(8):58-61. Vestn Ross Akad Med Nauk. 1999. PMID: 10487126 Review. Russian.
Cited by
-
Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis.Br J Cancer. 2001 Sep 14;85(6):924-9. doi: 10.1054/bjoc.2001.2004. Br J Cancer. 2001. PMID: 11556847 Free PMC article.
-
The plasmin system is induced by and degrades amyloid-beta aggregates.J Neurosci. 2000 Jun 1;20(11):3937-46. doi: 10.1523/JNEUROSCI.20-11-03937.2000. J Neurosci. 2000. PMID: 10818128 Free PMC article.
-
The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells.J Biol Chem. 2009 Jun 19;284(25):17030-17038. doi: 10.1074/jbc.M109.010066. Epub 2009 Apr 21. J Biol Chem. 2009. PMID: 19383607 Free PMC article.
-
Sialylated Lewis x antigen bearing glycoproteins in human plasma.J Proteome Res. 2010 Nov 5;9(11):5960-8. doi: 10.1021/pr100747p. Epub 2010 Oct 11. J Proteome Res. 2010. PMID: 20858014 Free PMC article.
-
Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.Am J Pathol. 2000 Oct;157(4):1219-27. doi: 10.1016/S0002-9440(10)64637-8. Am J Pathol. 2000. PMID: 11021826 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous